Eli Lilly's growth is fueled by high demand for its key drugs, Mounjaro (for type 2 diabetes ... of 25.7% from the current levels. With headquarters in the heart of Chicago's financial district ...

FILE - A sign for Eli Lilly & Co. stands outside their corporate headquarters in Indianapolis on April 26 ... said that a nationwide shortage of Eli Lilly’s Zepbound and Mounjaro has been resolved, ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

FILE - A sign for Eli Lilly & Co. stands outside their corporate headquarters in Indianapolis ... shortage of Eli Lilly’s Zepbound and Mounjaro has been resolved, eliminating the need for ...

FILE - A sign for Eli Lilly & Co. stands outside their corporate headquarters in Indianapolis ... Zepbound is FDA-approved to treat obesity and Mounjaro is approved for diabetes.

The Food and Drug Administration said that a nationwide shortage of Eli Lilly’s Zepbound and Mounjaro has been ... which is also home to BXP’s headquarters and the three-story observatory ...

Lilly also announced other multibillion-dollar manufacturing expansion projects near its Indianapolis headquarters earlier this year. Eli Lilly and Co. said Thursday that it has slated more than $ ...

The U.S. Food and Drug Administration ruled Thursday that the shortage of tirzepatide — the active ingredient in Eli Lilly’s (LLY) popular diabetes and weight-loss drugs Mounjaro and Zepbound ...